Details for Patent: 12,090,135
✉ Email this page to a colleague
Which drugs does patent 12,090,135 protect, and when does it expire?
Patent 12,090,135 protects BEIZRAY and is included in one NDA.
This patent has three patent family members in two countries.
Summary for Patent: 12,090,135
| Title: | Neutral pH compositions of docetaxel and human serum albumin |
| Abstract: | This document relates to non-covalently bound complexes including Docetaxel and human serum albumin, and to compositions comprising such complexes. This document also relates to compositions comprising Docetaxel and human serum albumin, wherein the composition is a clear aqueous solution when the composition is dissolved in an aqueous solution, and wherein the composition has a solubility in an aqueous solution of at least 10 mg/ml. This document also relates to compositions comprising Docetaxel and human serum albumin, wherein the Docetaxel and the human serum albumin in the composition have a weight ratio from about 1:50 to about 1:1000. This document also relates to compositions consisting essentially of Docetaxel and human serum albumin, wherein the Docetaxel and the human serum albumin in the composition have a weight ratio from about 1:50 to about 1:1000. The pH of the docetaxel compositions of the present disclosure is from about 5 to about 8. |
| Inventor(s): | Qun Sun |
| Assignee: | Zhuhai Beihai Biotech Co Ltd |
| Application Number: | US17/882,391 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 12,090,135
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhuhai | BEIZRAY | docetaxel | SOLUTION;INTRAVENOUS | 218711-001 | Oct 23, 2024 | RX | Yes | Yes | 12,090,135 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,090,135
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| China | 110062622 | ⤷ Start Trial | |||
| China | 115487312 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2018081520 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
